Fingerprint
Dive into the research topics of 'A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17-11)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17-11)
Hyun Ae Jung, Keon Uk Park, Sanghee Cho, Jinyeong Lim, Keun Wook Lee, Min Hee Hong, Tak Yun, Ho Jung An, Woong Yang Park, Sergio Pereira, Chan Young Ock, Bhumsuk Keam
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations